But last year, the weight-loss drug Wegovy ... prescriptions of other drugs among those patients fell by about 3%. Those who received the drugs were just a fraction of young people who struggle ...

Ore Huiying / Bloomberg / Getty Images Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that ...

As semaglutide gains popularity for weight loss, youth express significant concerns about its safety and appropriate use, particularly given their heightened engagement with social media and ...

(Bloomberg) -- Eli Lilly & Co. shares surged after its experimental pill helped patients shed weight and control blood ... Shares of the drug’s originator Chugai Pharmaceutical Co. also soared.

a GLP-1 weight-loss pill, led to significant weight and A1C reductions. The pill form could expand access and reduce costs compared with injectable GLP-1 drugs. The move: Eli Lilly stock soared as ...

Semaglutide is the active ingredient in weight loss drugs Ozempic and Wegovy. Since 2020, the dispense rate for semaglutide among teens and young adults has increased by nearly 600%.